CenterStar Asset Management’s iShares Biotechnology ETF IBB Stock Holding History

CenterStar Asset Management’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Hold	–	-$5.69K	–	234
2022 Q4	–	Hold	–	–	–	5
2022 Q3	–	Hold	–	–	–	329
2022 Q2	–	Hold	–	–	–	91
2022 Q1	–	Hold	–	–	–	61
2021 Q4	–	Hold	–	–	–	70
2021 Q3	–	Hold	–	–	–	26
2021 Q2	–	Hold	–	–	–	191
2021 Q1	–	Hold	–	–	–	252
2020 Q4	–	Hold	–	–	–	47
2019 Q4	–	Hold	–	-$3K	–	530
2019 Q3	–	Hold	–	–	–	395
2019 Q2	–	Hold	–	–	–	72
2019 Q1	–	Hold	–	–	–	74
2018 Q4	–	Hold	–	–	–	398
2018 Q3	–	Hold	–	–	–	393
2018 Q2	–	Hold	–	–	–	263
2018 Q1	–	Hold	–	–	–	408
2017 Q4	–	Hold	–	–	–	542

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

CenterStar Asset Management's IBB Position: Q4 2024 in Review

CenterStar Asset Management sold out of iShares Biotechnology ETF (IBB) in Q4 2024, closing a stake of 2,652 shares — an estimated $386K sold.

CenterStar Asset Management first reported a position in IBB in Q1 2024 and held it in 2 quarters. The position peaked at $386K in Q3 2024. 875 funds tracked by Wall St. Rank hold IBB as of Q4 2024.

CenterStar Asset Management reported no remaining iShares Biotechnology ETF position as of Q4 2024 after selling out during the quarter.
CenterStar Asset Management sold 2,652 iShares Biotechnology ETF shares in Q4 2024, an estimated $386K.
CenterStar Asset Management first reported a position in iShares Biotechnology ETF in Q1 2024 and held it in 2 quarters.
CenterStar Asset Management's iShares Biotechnology ETF position peaked at $386K in Q3 2024.
875 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2024.

Based on CenterStar Asset Management's 13F filing for Q4 2024, filed 27 Jan 2025.